Literature DB >> 19869635

THE ANTIBODY RESPONSE IN THE HUMAN BEING AFTER INJECTION WITH NORMAL HORSE SERUM.

L Tuft1, S G Ramsdell.   

Abstract

After the injection of normal horse serum in the human being, serum sickness occurs even more regularly than in cases treated with the various immune sera, but this is not accompanied by the production, to any notable degree, of circulating antibodies of the various types that are regularly to be demonstrated after the administration of immune serum and its resulting serum sickness. Since normal horse serum therefore appears to be weakly antigenic, and immune serum highly antigenic for the human being, one must assume that this difference is the result of some alteration in its antigenic characteristics produced during the course of the immunization or of its preparation for use; or that the specific antibody which is responsible for the phenomenon of serum sickness has not yet been identified; or that this phenomenon is not in any way dependent on the presence of the various known antibodies to normal horse serum.

Entities:  

Year:  1929        PMID: 19869635      PMCID: PMC2131647          DOI: 10.1084/jem.50.4.431

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  1 in total

1.  THE RELATION OF CIRCULATING ANTIBODIES TO SERUM DISEASE.

Authors:  W T Longcope; F M Rackemann
Journal:  J Exp Med       Date:  1918-03-01       Impact factor: 14.307

  1 in total
  3 in total

1.  [Not Available].

Authors:  F KNUCHEL; W KNUCHEL
Journal:  Klin Wochenschr       Date:  1948-05-15

2.  SERUM SICKNESS IN RABBITS : II. PRECIPITINOGEN AND PRECIPITINS IN RELATION TO APPEARANCE OF THE REACTION.

Authors:  L Jones; M S Fleisher
Journal:  J Exp Med       Date:  1932-01-01       Impact factor: 14.307

3.  Human antibodies neutralizing diphtheria toxin in vitro and in vivo.

Authors:  Paul Stickings; Michael Hust; Esther Veronika Wenzel; Margarita Bosnak; Robert Tierney; Maren Schubert; Jeffrey Brown; Stefan Dübel; Androulla Efstratiou; Dorothea Sesardic
Journal:  Sci Rep       Date:  2020-01-17       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.